Kolexia
Wacrenier Samuel
Néphrologie
Centre Hospitalier du Mans
Le Mans, France
42 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Glomérulonéphrite Vascularite Défaillance rénale chronique Maladies du rein Atteinte rénale aigüe Vascularites associées aux anticorps anti-cytoplasme des neutrophiles Insuffisance rénale chronique Infarctus Lymphopénie

Industries

Sanofi
1 collaboration(s)
Dernière en 2020
AstraZeneca
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis.
Clinical kidney journal   04 juillet 2023
#4006 ADDING 6-MONTH PARAMETERS FOR THE PREDICTION OF RENAL PROGNOSIS IN ANCA-ASSOCIATED GLOMERULONEPHRITIS
60th ERA Congress, 15-18 June 2023: Congress Abstracts   14 juin 2023
#4027 KIDNEY INJURY MOLECULE 1 (KIM-1): A POTENTIAL BIOMARKER OF ACUTE KIDNEY INJURY AND TUBULOINTERSTITIAL INJURY IN PATIENTS WITH ANCA-GLOMERULONEPHRITIS
60th ERA Congress, 15-18 June 2023: Congress Abstracts   14 juin 2023
Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association   05 mai 2023
Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis.
Clinical kidney journal   03 avril 2023
Kidney injury molecule 1 (KIM-1) : biomarqueur d’insuffisance rénale aiguë et d’atteinte tubulo-interstitielle dans les vascularites à ANCA avec atteinte rénale
Congrès SFNDT 2022   01 septembre 2022
Histopathological prognostic factors in ANCA-associated glomerulonephritis.
Autoimmunity reviews   11 juillet 2022
Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association   26 mai 2022
Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis.
Frontiers in immunology   22 mars 2022
Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki ., , June 2021, DOI: 10.1016/j.ekir.2021.05.043).
Kidney international reports   07 septembre 2021